Product

Xeruborbactam

Aliases

QPX7831, QPX7831 Placebo, Xeruborbactam Oral Prodrug, Xeruborbactam Oral Prodrug Placebo

2 clinical trials

1 indication

Indication

Bacterial Infections

Clinical trial

A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of ORAvance (Ceftibuten/Xeruborbactam Oral Prodrug [QPX7831]) in Participants With Renal Impairment

Status: Not yet recruiting, Estimated PCD: 2025-02-01

Clinical trial

A Phase 1, Open-Label, Drug-drug Interaction, and Randomized, Double-blind, Controlled, Multiple-dose Pharmacokinetics and Safety Study of Xeruborbactam Oral Prodrug (QPX7831) in Combination With Ceftibuten in Healthy Adult Participants

Status: Recruiting, Estimated PCD: 2024-09-12